52
Views
6
CrossRef citations to date
0
Altmetric
Meeting Report

New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents

&
Pages 1121-1124 | Published online: 09 Jan 2014

References

  • Sharma HS. 4th Global College of Neuroprotection and Neuroregeneration Meeting. Expert Rev. Neurother.7(6), 595–598 (2007).
  • Sharma HS. 10th International Conference on Amino Acids and Protein. Expert Rev. Neurother.7(11), 1479–1484 (2007).
  • Sharma HS. 5th Annual Global College of Neuroprotection and Neuroregeneration. Expert Rev. Neurother.8(6), 881–887 (2008).
  • Sharma HS, Sharma A. 6th Global College of Neuroprotection and Neuroregeneration, annual meeting. Expert Rev. Neurother.9(7), 941–947 (2009).
  • Sharma HS, Sharma A. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part I. Expert Rev. Neurother.10(7), 1039–1043 (2010).
  • Sharma HS, Sharma A. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part II. Expert Rev. Neurother.10(8), 1253–1257 (2010).
  • Sharma HS, Sharma A. Conference scene: nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives. Nanomedicine5(4), 533–537 (2010).
  • Raisman G, Carlstedt T, Choi D, Li Y. Clinical prospects for transplantation of OECs in the repair of brachial and lumbosacral plexus injuries: opening a door. Exp. Neurol.229(1), 168–173 (2011).
  • Wu MM, Fan DG, Tadmori I et al. Death of axotomized retinal ganglion cells delayed after intraoptic nerve transplantation of olfactory ensheathing cells in adult rats. Cell Transplant.19(2), 159–166 (2010).
  • Sharma HS, Ali S, Tian ZR et al. Nano-drug delivery and neuroprotection in spinal cord injury. J. Nanosci. Nanotechnol.9(8), 5014–5037 (2009).
  • Sharma HS, Ali SF, Tian ZR et al. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood–brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J. Nanosci. Nanotechnol.9(8), 5073–5090 (2009).
  • Sharma HS, Patnaik R, Sharma A. Diabetes aggravates nanoparticles induced breakdown of the blood–brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol.10(12), 7931–7945 (2010).
  • Huang H, Chen L, Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med.1(1), 15–46 (2010).
  • Muresanu DF, Sharma A, Sharma HS. Diabetes aggravates heat stress-induced blood–brain barrier breakdown, reduction in cerebral blood flow, edema formation, and brain pathology: possible neuroprotection with growth hormone. Ann. NY Acad. Sci.1199, 15–26 (2010).
  • Sharma HS, Zimmermann-Meinzingen S, Johanson CE. Cerebrolysin reduces blood–cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat. Ann. NY Acad. Sci.1199, 125–137 (2010).
  • Menon PK. Effects of cerebrolysin, a mixture of neurotrophins on spinal cord injury in relation to nanoparticles treatment. Master’s Thesis, Uppsala University, Uppsala, Sweden, 1–28 (2011).
  • Sharma HS. Blood–CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery. J. Neural Transm.118(1), 3–6 (2011).
  • Sharma HS. Early microvascular reactions and blood–spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection. J. Neural Transm.118(1), 155–176 (2011).
  • Sharma HS, Muresanu DF, Sharma A, Patnaik R, Lafuente JV. Nanoparticles influence pathophysiology of spinal cord injury and repair. Prog. Brain Res.180, 154–180 (2009).
  • Grünblatt E, Bartl J, Riederer P. The link between iron, metabolic syndrome, and Alzheimer’s disease. J. Neural Transm.118(3), 371–379 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.